Shopping Cart
- Remove All
Your shopping cart is currently empty
Product Description- A unique collection of 1544 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS);
- Bioactivity and safety confirmed by pre-clinical research and clinical trials and most of them are approved for marketing by FDA, EMA, or NMPA;
- Covers various major targets including CYP, FAAH, IDO, MAO, etc., in diabetes, obesity, hypertriglyceridemia, hypercholesterolemia, etc.; Effective tool for cell metabolism research;
- Detailed compound information with structure, target, activity, IC50 value, and biological activity description;
- Structurally diverse, medicinally active, and cell permeable;
- NMR and HPLC validated to ensure high purity and quality;
Packaging And Storage
Supporting Files
Feedback
